tiprankstipranks
CytoMed Therapeutics Limited (GDTC)
NASDAQ:GDTC
US Market
GDTC
CytoMed Therapeutics Limited
RESEARCH TOOLSreports

CytoMed Therapeutics Limited (GDTC) Financial Statements

23 Followers

CytoMed Therapeutics Limited Financial Overview

CytoMed Therapeutics Limited's market cap is currently $11.83M. The company's EPS TTM is $; its P/E ratio is -7.53; CytoMed Therapeutics Limited is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Mar 24Dec 22Dec 21
Income Statement
Total Revenue$ 248.27K$ 52.01K$ 290.56K$ 0.00$ 84.18K
Gross Profit$ -689.55K$ 52.38K$ 381.92K$ -81.03K$ 81.59K
Operating Income$ -3.52M$ -2.63M$ -3.20M$ -1.70M$ -1.40M
EBITDA$ -3.34M$ -1.79M$ -2.94M$ -1.10M$ -1.05M
Net Income$ -3.05M$ -1.88M$ -3.13M$ -2.27M$ -1.53M
Balance Sheet
Cash & Short-Term Investments$ 2.10M$ 3.64M$ 6.82M$ 1.18M$ 1.87M
Total Assets$ 7.98M$ 7.37M$ 9.37M$ 3.90M$ 4.51M
Total Debt$ 482.56K$ 339.20K$ 339.50K$ 3.15M$ 2.42M
Net Debt$ -1.61M$ -3.30M$ -6.48M$ 1.97M$ 553.08K
Total Liabilities$ 1.13M$ 749.76K$ 852.28K$ 3.46M$ 2.59M
Stockholders' Equity$ 6.54M$ 6.57M$ 8.52M$ 438.24K$ 1.92M
Cash Flow
Free Cash Flow$ -4.40M$ -3.01M$ -2.72M$ -1.40M$ -1.70M
Operating Cash Flow$ -3.70M$ -1.98M$ -2.68M$ -1.04M$ -1.27M
Investing Cash Flow$ 929.28K$ 494.59K$ -2.11M$ -353.37K$ -610.72K
Financing Cash Flow$ 208.65K$ -33.36K$ 8.16M$ 793.25K$ 3.09M
Currency in USD

CytoMed Therapeutics Limited Earnings and Revenue History

Income Statement >

CytoMed Therapeutics Limited Debt to Assets

Balance Sheet >

CytoMed Therapeutics Limited Cash Flow

Cash Flow >

CytoMed Therapeutics Limited Forecast EPS vs Actual EPS

Earnings >